Showing results (341-350 of 384) with videos related to

Sort By:
Pageof 39
Cancer|August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neckNabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
The Laryngoscope|January 16, 2026
Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRPSimon R Best, Aaron D Friedman, Clark A Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell CarcinomaDan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 26, 2025
Radiotherapy With Cisplatin vs Carboplatin Paclitaxel for Head and Neck Squamous Cell CarcinomaMarin Abousaud, Saagar Pamulapati, Saad Rashid, et al.
Cancers|December 17, 2024
Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal MalignanciesElisabetta Xue, Dara Bracken-Clarke, Harris Krause, et al.
The New England Journal of Medicine|October 11, 2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckRobert L Ferris, George Blumenschein, Jerome Fayette, et al.
Cancer Medicine|December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G Pfister, Robert I Haddad, Francis P Worden, et al.
JAMA|March 13, 2025
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical TrialRobert Haddad, Jérôme Fayette, Maria Teixeira, et al.
Oral Oncology|November 19, 2021
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?Pawel Golusinski, June Corry, Vincent Vander Poorten, et al.
The Lancet. Oncology|June 28, 2017
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trialKevin J Harrington, Robert L Ferris, George Blumenschein, et al.
Pageof 39